P1.17-07 Neoadjuvant Gefitinib in Resectable Early Stage EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): A Window-of-Opportunity Study

التفاصيل البيبلوغرافية
العنوان: P1.17-07 Neoadjuvant Gefitinib in Resectable Early Stage EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): A Window-of-Opportunity Study
المؤلفون: T. Rajasekaran, T. Koh, K.P. Chua, Weiwei Zhai, B.H. Ong, Daniel Shao Weng Tan, Aaron Tan, G. Lai, Wan-Teck Lim, Angela Takano, Mei-Kim Ang, Zaw Win Aung, Chee Keong Toh, Amit Jain, Wan Ling Tan, Anders Jacobsen Skanderup, Eng Huat Tan, Quan Sing Ng, Jacob Josiah Santiago Alvarez, N.G. Iyer, Ravindran Kanesvaran
المصدر: Journal of Thoracic Oncology. 14:S609-S610
بيانات النشر: Elsevier BV, 2019.
سنة النشر: 2019
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Window of opportunity, Gefitinib, Oncology, business.industry, Mutant, medicine, Cancer research, non-small cell lung cancer (NSCLC), Stage (cooking), medicine.disease, business, medicine.drug
تدمد: 1556-0864
DOI: 10.1016/j.jtho.2019.08.1281
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e3904c2c378da1c6b0e25266bc716412
https://doi.org/10.1016/j.jtho.2019.08.1281
Rights: OPEN
رقم الانضمام: edsair.doi...........e3904c2c378da1c6b0e25266bc716412
قاعدة البيانات: OpenAIRE
الوصف
تدمد:15560864
DOI:10.1016/j.jtho.2019.08.1281